St. John's Wort and its Active Principles in Depression and Anxiety

  • Walter E. Müller

Part of the Milestones in Drug Therapy MDT book series (MDT)

Table of contents

  1. Front Matter
    Pages I-VIII
  2. Walter E. Müller
    Pages 1-4
  3. Kurt Hostettmann, Jean-Luc Wolfender
    Pages 5-20
  4. Kristina Treiber, Walter E. Müller
    Pages 31-46
  5. Jan Kehr, Sven Ove Ögren, Takashi Yoshitake
    Pages 47-58
  6. Carla Gambarana, Daniela Giachetti
    Pages 59-71
  7. Mario Wurglics, Manfred Schubert-Zsilavecz
    Pages 99-121
  8. Siegfried Kasper
    Pages 123-131
  9. Volker Schulz, Andreas Johne
    Pages 145-160
  10. Michael Franklin
    Pages 161-181
  11. Back Matter
    Pages 183-188

About this book


Hypericum extract preparations are used extensively in many countries to treat mildly to moderately depressed patients. While this was based previously on traditional experience, extensive research over the last 10 years has given a broad preclinical and clinical basis to justify the use of Hypericum as an antidepressant. This book reviews the available data related to the biochemical, functional, and behavioural pharmacology of Hypericum and its active constituents. The clinical chapters overview the evidenced basis for its use as an antidepressant, initial data in anxiety and somatoform disorders, and the site effect profile of Hypericum and its possible relevant drug interactions. The known pharmacokinetics of the relevant constituents and the biopharmaceutical quality of commercially available Hypericum preparations are also discussed.


Antidepressant Activity Biophamaceutics Depression Neurotransmitter Metabolism Pharmacokinetics Phytochemistry anxiety metabolism

Editors and affiliations

  • Walter E. Müller
    • 1
  1. 1.Pharmakologisches Institut für NaturwissenschaftlerBiozentrum Universität FrankfurtFrankfurtGermany

Bibliographic information

Industry Sectors
Health & Hospitals
Pharmacology & Toxicology
Consumer Packaged Goods